MedPath

Management of Urinary incontinence in Post Hysterectomy and Post Menopausal Women with Unani drug.

Phase 2
Conditions
Health Condition 1: N329- Bladder disorder, unspecified
Registration Number
CTRI/2022/08/044851
Lead Sponsor
DR TAHSEEN TABBASSUM
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Female patients of age less than 60yrs.

Postmenopausal women.

Patients with post hysterectomy urinary incontinence.

Clinically stable patients.

Exclusion Criteria

Women with Urinary tract infection.

Diabetic patients.

Women with renal disorders.

Patients on diuretics.

Patients with 2nd,3rd, and 4th-degree uterine prolapse.

Urogenital malignancy.

Patients with deranged kidney, hepatic and cardiac profile

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Any effect like cure, relieved or uneffectedTimepoint: 3 months
Secondary Outcome Measures
NameTimeMethod
Any effect on quality of lifeTimepoint: 18 months
© Copyright 2025. All Rights Reserved by MedPath